In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections
BACKGROUND The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of imple...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
The incidence of hepatitis C virus (HCV) infections among human immunodeficiency virus (HIV)-infecte...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
BACKGROUND AND AIMS: Treatment for chronic hepatitis C virus (HCV) infections changed dramatically i...
BACKGROUND AND AIMS: Treatment for chronic hepatitis C virus (HCV) infections changed dramatically i...
In the Swiss HIV Cohort Study, a nationwide cohort with systematic hepatitis C virus (HCV) infection...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
BACKGROUND: The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of impleme...
BACKGROUND: The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of impleme...
BACKGROUND The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of imple...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
The incidence of hepatitis C virus (HCV) infections among human immunodeficiency virus (HIV)-infecte...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C vi...
BACKGROUND AND AIMS: Treatment for chronic hepatitis C virus (HCV) infections changed dramatically i...
BACKGROUND AND AIMS: Treatment for chronic hepatitis C virus (HCV) infections changed dramatically i...
In the Swiss HIV Cohort Study, a nationwide cohort with systematic hepatitis C virus (HCV) infection...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
BACKGROUND: The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of impleme...
BACKGROUND: The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of impleme...
BACKGROUND The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of imple...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
The incidence of hepatitis C virus (HCV) infections among human immunodeficiency virus (HIV)-infecte...